Table 3 Correlation between lncRNA BLACAT1 and clinicopathological traits in all patients with PTMC
From: Prognostic value of long non-coding RNA BLACAT1 in patients with papillary thyroid carcinoma
Parameters | lncRNA BLACAT1 | χ2 | P | |
|---|---|---|---|---|
Low (%) | High (%) | |||
(n = 31) | (n = 31) | |||
Sex | ||||
Male | 11 (35.48) | 6 (19.35) | 5.823 | 0.017* |
Female | 20 (64.52) | 25 (80.65) | ||
Age (years) | ||||
< 45 | 12 (38.71) | 14 (45.16) | 0.000 | 1.000 |
≥ 45 | 19 (61.29) | 17 (54.84) | ||
Extrathyroidal extension | ||||
Positive | 9 (29.03) | 16 (51.61) | 2.013 | 0.364 |
Negative | 22 (70.97) | 15 (48.39) | ||
TNM staging | ||||
I/II | 5 (16.13) | 4 (12.90) | 0.516 | 0.849 |
III/IV | 26 (83.87) | 27 (87.10) | ||
Lymph node metastasis | ||||
Positive | 20 (64.52) | 10 (32.26) | 9.014 | 0.005* |
Negative | 11 (35.48) | 21 (67.74) | ||
Multifocality | ||||
Positive | 12 (38.71) | 10 (32.26) | 0.323 | 0.9240 |
Negative | 19 (61.29) | 21 (67.74) | ||
Hashimoto thyroiditis | ||||
Positive | 8 (25.81) | 9 (29.03) | 0.092 | 1.000 |
Negative | 23 (74.19) | 22 (70.97) | ||
Nodular goiter | ||||
Positive | 16 (51.61) | 13 (41.94) | 0.841 | 0.603 |
Negative | 15 (48.39) | 18 (58.06) | ||